FORT MYERS, Fla., April 26, 2024 /PRNewswire/ — Florida Cancer Specialists & Research Institute, LLC (FCS) President & Managing Physician Lucio N. Gordan, MD will serve as a panelist at the 2024 Oncology Fellows & Faculty Forum in Miami, sponsored by PrecisCa and the Community Oncology Alliance (COA). Dr. Gordan will participate with oncology physician executives for the Oncology Leaders in Business and Practice panel discussion.
Lucio N. Gordan will be a featured panelist at the Community Oncology Alliance PrecisCa Oncology Fellows & Faculty Forum.
“I consider it a great privilege to spend time with these young physicians as they prepare to launch their medical careers,” Dr. Gordan said. “In this dynamic setting, my colleagues and I will share real-world experiences encompassing the many unique and often complex facets of the oncology field beyond clinical practice.”
The exclusive three-day gathering provides oncology professionals with opportunities to interact with the world’s oncology experts. Through networking sessions and panel discussions they gain insights into the latest advancements and breakthroughs in oncology research and treatment and guidance to enhance their leadership skills and business acumen.
PrecisCa provides patients and providers with access to world-class cancer experts to enhance the quality of cancer, including a range of content offerings, educational opportunities and peer-to-peer mentorship to develop oncology’s future emerging leaders. The Community Oncology Alliance (COA) is a non-profit organization solely dedicated to advocating for community oncology practices and the patients they serve.
About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. The majority of new cancer drugs recently approved for use in the U.S. were studied in clinical trials with FCS participation.* Recognized for our research, FCS is a recipient of the national Clinical Trials Participation Award presented by the American Society of Clinical Oncology (ASCO). FCS physicians, trained in prestigious medical schools and research institutes, are consistently ranked nationally as Top Doctors by U.S. News & World Report.
Celebrating its 40th year in 2024, FCS has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies genomic-based treatment and immunotherapy. Our highest values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians and staff.
*Prior to approval
SOURCE Florida Cancer Specialists & Research Institute
